362 related articles for article (PubMed ID: 26597208)
1. Complement system activation in ANCA vasculitis: A translational success story?
Kallenberg CG; Heeringa P
Mol Immunol; 2015 Nov; 68(1):53-6. PubMed ID: 26597208
[TBL] [Abstract][Full Text] [Related]
2. The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy.
Trivioli G; Vaglio A
Clin Exp Immunol; 2020 Dec; 202(3):403-406. PubMed ID: 32946609
[TBL] [Abstract][Full Text] [Related]
3. Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation.
Ohlsson S; Holm L; Hansson C; Ohlsson SM; Gunnarsson L; Pettersson Ã…; Skattum L
PLoS One; 2019; 14(6):e0218272. PubMed ID: 31216309
[TBL] [Abstract][Full Text] [Related]
4. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
[TBL] [Abstract][Full Text] [Related]
5. C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis.
Dick J; Gan PY; Ford SL; Odobasic D; Alikhan MA; Loosen SH; Hall P; Westhorpe CL; Li A; Ooi JD; Woodruff TM; Mackay CR; Kitching AR; Hickey MJ; Holdsworth SR
Kidney Int; 2018 Mar; 93(3):615-625. PubMed ID: 29241626
[TBL] [Abstract][Full Text] [Related]
6. Complement in ANCA-associated vasculitis.
Charles Jennette J; Xiao H; Hu P
Semin Nephrol; 2013 Nov; 33(6):557-64. PubMed ID: 24161040
[TBL] [Abstract][Full Text] [Related]
7. A pro-inflammatory role of C5L2 in C5a-primed neutrophils for ANCA-induced activation.
Hao J; Wang C; Yuan J; Chen M; Zhao MH
PLoS One; 2013; 8(6):e66305. PubMed ID: 23785491
[TBL] [Abstract][Full Text] [Related]
8. The role of neutrophils in causing antineutrophil cytoplasmic autoantibody-associated vasculitis.
Schreiber A; Choi M
Curr Opin Hematol; 2015 Jan; 22(1):60-6. PubMed ID: 25394311
[TBL] [Abstract][Full Text] [Related]
9. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis.
Schreiber A; Rousselle A; Becker JU; von Mässenhausen A; Linkermann A; Kettritz R
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9618-E9625. PubMed ID: 29078325
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil extracellular traps can activate alternative complement pathways.
Wang H; Wang C; Zhao MH; Chen M
Clin Exp Immunol; 2015 Sep; 181(3):518-27. PubMed ID: 25963026
[TBL] [Abstract][Full Text] [Related]
11. The interaction between C5a and sphingosine-1-phosphate in neutrophils for antineutrophil cytoplasmic antibody mediated activation.
Hao J; Huang YM; Zhao MH; Chen M
Arthritis Res Ther; 2014 Jul; 16(4):R142. PubMed ID: 25000985
[TBL] [Abstract][Full Text] [Related]
12. The complement system in antineutrophil cytoplasmic antibody-associated vasculitis: pathogenic player and therapeutic target.
Mazzariol M; Manenti L; Vaglio A
Curr Opin Rheumatol; 2023 Jan; 35(1):31-36. PubMed ID: 36301247
[TBL] [Abstract][Full Text] [Related]
13. Complement alternative pathway in ANCA-associated vasculitis: Two decades from bench to bedside.
Brilland B; Garnier AS; Chevailler A; Jeannin P; Subra JF; Augusto JF
Autoimmun Rev; 2020 Jan; 19(1):102424. PubMed ID: 31734405
[TBL] [Abstract][Full Text] [Related]
14. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.
Schreiber A; Xiao H; Jennette JC; Schneider W; Luft FC; Kettritz R
J Am Soc Nephrol; 2009 Feb; 20(2):289-98. PubMed ID: 19073822
[TBL] [Abstract][Full Text] [Related]
15. Complement inhibition in ANCA vasculitis.
Jayne D
Nephrol Ther; 2019 Nov; 15(6):409-412. PubMed ID: 31631015
[TBL] [Abstract][Full Text] [Related]
16. Complement in ANCA-associated vasculitis: mechanisms and implications for management.
Chen M; Jayne DRW; Zhao MH
Nat Rev Nephrol; 2017 Jun; 13(6):359-367. PubMed ID: 28316335
[TBL] [Abstract][Full Text] [Related]
17. Experimental models of vasculitis and glomerulonephritis induced by antineutrophil cytoplasmic autoantibodies.
Jennette JC; Xiao H; Falk R; Gasim AMH
Contrib Nephrol; 2011; 169():211-220. PubMed ID: 21252521
[TBL] [Abstract][Full Text] [Related]
18. Promotion of hypercoagulability in antineutrophil cytoplasmic antibody-associated vasculitis by C5a-induced tissue factor-expressing microparticles and neutrophil extracellular traps.
Huang YM; Wang H; Wang C; Chen M; Zhao MH
Arthritis Rheumatol; 2015 Oct; 67(10):2780-90. PubMed ID: 26097236
[TBL] [Abstract][Full Text] [Related]
19. Complement in ANCA-associated glomerulonephritis.
Hilhorst M; van Paassen P; van Rie H; Bijnens N; Heerings-Rewinkel P; van Breda Vriesman P; Cohen Tervaert JW;
Nephrol Dial Transplant; 2017 Aug; 32(8):1302-1313. PubMed ID: 26275893
[TBL] [Abstract][Full Text] [Related]
20. p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation.
Hao J; Meng LQ; Xu PC; Chen M; Zhao MH
PLoS One; 2012; 7(5):e38317. PubMed ID: 22675451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]